Organization | ARCIM Institute

ARCIM Institute Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2014

NCT02285452

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Alternative names

Arcim Institute | ARCIM Institute | ARCIM-Institute | ARCIM Institute Academic Research in Complementary and Integrative Medicine | ARCIM Institute; University of Tuebingen

Active Ingredients

Drugs in Other Trials (7)

ginger (3 trials)

ginger extract (1 trial)

mustard (2 trials)

mustard flour (1 trial)

rosemary oil (1 trial)

sinapis nigrea semen (1 trial)

zingiberis rhizoma plv. (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 7
# of Trial APIs: 7